Polymyxin B stabilized DNA micelles for sustained antibacterial and antibiofilm activity against P. aeruginosa .
Alexandra SousaVegard BorøyAgnethe BæverudKjersti JulinAnnette BayerMorten StrømMona JohannessenNataša Škalko-BasnetSybil ObuobiPublished in: Journal of materials chemistry. B (2023)
Nucleic acid-based materials showcase an increasing potential for antimicrobial drug delivery. Although numerous reports on drug-loaded DNA nanoparticles outline their pivotal antibacterial activities, their potential as drug delivery systems against bacterial biofilms awaits further studies. Among different oligonucleotide structures, micellar nanocarriers derived from amphiphilic DNA strands are of particular interest due to their spontaneous self-assembly and high biocompatibility. However, their clinical use is hampered by structural instability upon cation depletion. In this work, we used a cationic amphiphilic antibiotic (polymyxin B) to stabilize DNA micelles destined to penetrate P. aeruginosa biofilms and exhibit antibacterial/antibiofilm properties. Our study highlights how the strong affinity of this antibiotic enhances the stability of the micelles and confirms that antibacterial activity of the novel micelles remains intact. Additionally, we show that PMB micelles can penetrate P. aeruginosa biofilms and impact their metabolic activity. Finally, PMB micelles were highly safe and biocompatible, highlighting their possible application against P. aeruginosa biofilm-colonized skin wounds.
Keyphrases
- drug delivery
- drug release
- nucleic acid
- cancer therapy
- circulating tumor
- cell free
- candida albicans
- single molecule
- silver nanoparticles
- staphylococcus aureus
- wound healing
- pseudomonas aeruginosa
- risk assessment
- hyaluronic acid
- human health
- circulating tumor cells
- high resolution
- mass spectrometry
- biofilm formation
- cystic fibrosis
- gram negative
- climate change
- adverse drug
- drug induced
- tissue engineering